First Light Asset Management, LLC Amgen Inc Transaction History

First Light Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $242,325 - $282,391	-1,092 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $2,351 - $2,650	-13 Reduced 1.18%	1,092 $207,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $183,485 - $206,093	1,105 New	1,105 $204,000
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $186,512 - $208,391	-1,105 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $184,855 - $211,055	1,105	1,105 $207,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.